BioCardia Inc (BCDA) Cash Funds per Single Share

Global logistics risks and patent disputes are driving volatility, making the monitoring of cash per share essential to assess the resilience of BioCardia, Inc. (BCDA). The 0.15 mark reflects the current state of liquidity. Meanwhile, management is persistently developing cell therapy, while financial stability temporarily relies on remaining invested capital in the absence of regular profits.
Comprehensive metric breakdowns and analytics for BioCardia Inc. (BCDA)

BioCardia, Inc. (BCDA) liquidity dynamics are reflected in the cash per share chart. This metric determines the portion of free cash resources attributable to a single unit of capital. The calculation is based on dividing the total cash on the balance sheet by the number of shares outstanding. For a company in the high-risk cell therapy race, this reserve is critical for survival while competing with cardiac surgery. It is essential for the investor to maintain a balance between default protection and potential yield.